Ongoing HER2 Therapy May Cost an Additional $68,000 per Patient Ongoing HER2 Therapy May Cost an Additional $68,000 per Patient

Meeting the treatment needs of the nearly 50% of women with metastatic breast cancer in British Columbia who could benefit from continued HER2 suppression would cost at least $68,000 more per patient.Medscape Medical News
Source: Medscape Hematology-Oncology Headlines - Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news